We bring you the news you might have missed from the week just gone. The top lines this week: The Swiss city of Zürich launches its adult-use cannabis pilot, Israel’s major reforms aim to make medical cannabis a ‘first line treatment’, and a global study will [...]
Via Business of Cannabis Israel could soon see a dramatic increase in the number of medical cannabis patients as the government publishes proposals for sweeping reforms aimed at streamlining access. On Monday 7 August, The Health Ministry published its highly anticipated proposals for medical cannabis reform in [...]
In his final instalment, consultant psychiatrist and cannabis clinician Dr Tahzid Ahsan, explores the potential of cannabis in managing symptoms of ADHD and autism. Around three in 10 autistic adults and around 28% of autistic children also have ADHD. The likelihood of someone presenting with both [...]
Cannabis scientist Lex Pelger brings you the latest cannabinoid research with new studies exploring CBD for ageing and hair growth, plus fibromyalgia, Alzheimer’s, binge eating disorder and more. Lex Pelger is a biochemist specialising in cannabinoids and psychedelics. Here we share an extract from his newsletter, [...]
The Swiss city of Zurich has marked a significant milestone with the official launch of its cannabis pilot trial ‘ZüriCan’ this week. The trials represent a major development in the legalisation and regulation of cannabis in Switzerland. The second pilot, which began on Tuesday 22 August, [...]
A new study highlights the myriad of benefits medical cannabis can have on patients’ quality of life, from reducing symptoms to boosting energy levels and job performance. Researchers in Greece studied a group of patients receiving medical cannabis treatment to try to understand how it impacted [...]
After the US, the UK saw the second highest number of clinical trials carried out on cannabinoids in the last decade, according to a new report. The upcoming report, due to be published this month by Prohibition Partners and Cannabiscientia, explores the progression of cannabis research [...]
Researchers in Australia will explore whether treatment with medicinal cannabis can ease the economic impact of chronic health conditions. Australians living with one of 200 chronic conditions may now be eligible to participate in what is expected to become the world’s largest study into the impact [...]
A dad-of-two, serving five years for supplying cannabis to help severely ill patients, has been moved to an open prison as his family prepare to launch an appeal against his sentence. The family of Patrick Moore, who was sentenced to five years for the cultivation and [...]
Founder and CEO Chase Eastman officially launched Rootwurks in January 2022. But the journey began years earlier, and passed through industries including food safety training and digital media and television. Rootwurks at its core is a training platform. The cannabis industry deals with an incredibly complex [...]
Late last month, Mastercard decided to halt their debit card transactions with cannabis dispensaries, notifying financial institutions and payment processors to stop processing purchases. This isn’t the first digital payment solution to swiftly exit the industry – late last year, vendors turned off services to their cashless ATMs. These abrupt [...]
This is Part One of a four-part series discussing European cannabis regulations. Part One serves as an introduction. Part Two, coming next week, will analyze the differences between the UK, the EU and the US. Stay tuned for more. As I walk through any European cannabis [...]
Copyright © 2024 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
